Adam R. Craig - 23 Oct 2025 Form 4 Insider Report for X4 Pharmaceuticals, Inc (XFOR)

Role
Executive Chairman, Director
Signature
/s/ David Kirske, Attorney-In-Fact
Issuer symbol
XFOR
Transactions as of
23 Oct 2025
Net transactions value
+$249,997
Form type
4
Filing time
27 Oct 2025, 18:40:40 UTC
Previous filing
14 Aug 2025
Next filing
31 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Craig Adam R Executive Chairman, Director C/O X4 PHARMACEUTICALS INC., 61 NORTH BEACON STREET, 4TH FLOOR, BOSTON /s/ David Kirske, Attorney-In-Fact 27 Oct 2025 0001339498

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XFOR Common Stock Purchase $249,997 +86,206 +30% $2.90 376,087 23 Oct 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares of the Issuer's common stock purchased in connection with the Issuer's public offering.